Nick Bassil is a partner in Kilburn & Strode’s London life sciences and chemistry team. His practice concentrates on pharmaceutical chemistry, regenerative medicine, immunotherapy, genome mapping and synthetic genome assembly. He has been significantly involved in patent applications relating to cloning (somatic cell nuclear transfer), stem cells, cancer immunotherapy/CAR-T cells, regenerative medicine, gene therapy, and monoclonal antibodies/novel antigen receptor proteins. His practice ranges from drafting original patent applications and devising filing strategies, to advising on IP aspects of company M&A. His European portfolio includes post-grant opposition proceedings at the EPO and SPCs for pharmaceuticals.